Abstract
Desonide foam is a newly approved topical corticosteroid preparation of 0.05% desonide. It has been shown effective compared with vehicle placebo in the treatment of mild-to-moderate atopic dermatitis in both pediatric and adult populations. Given the favorable safety profile of all other desonide preparations and their utility as a low potency corticosteroid, desonide foam promises to be a useful addition to the armamentarium, when other desonide vehicles might be less acceptable.
(c) 2008 Prous Science, S.A.U. or its licensors.
MeSH terms
-
Administration, Topical
-
Adrenal Cortex Hormones* / administration & dosage
-
Adrenal Cortex Hormones* / adverse effects
-
Adrenal Cortex Hormones* / pharmacology
-
Adrenal Cortex Hormones* / therapeutic use
-
Adult
-
Anti-Inflammatory Agents* / administration & dosage
-
Anti-Inflammatory Agents* / adverse effects
-
Anti-Inflammatory Agents* / pharmacology
-
Anti-Inflammatory Agents* / therapeutic use
-
Child
-
Dermatitis, Atopic / drug therapy*
-
Desonide* / administration & dosage
-
Desonide* / adverse effects
-
Desonide* / pharmacology
-
Desonide* / therapeutic use
-
Humans
-
Pharmaceutical Vehicles
Substances
-
Adrenal Cortex Hormones
-
Anti-Inflammatory Agents
-
Pharmaceutical Vehicles
-
Desonide